Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 4
1988 5
1989 14
1990 7
1991 3
1992 9
1993 6
1994 11
1995 7
1996 18
1997 16
1998 15
1999 18
2000 20
2001 17
2002 23
2003 10
2004 16
2005 20
2006 16
2007 20
2008 15
2009 12
2010 10
2011 6
2012 7
2013 8
2014 6
2016 4
2017 4
2018 4
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

341 results
Results by year
Filters applied: . Clear all
Page 1
Second-generation antihistamines: a comparative review
Slater JW, et al. Drugs 1999. PMID 9951950
In addition to their primary mechanism of antagonising histamine at the H1 receptor, these agents may act on other mediators of the allergic reaction. However, the clinical significance of activity beyond that mediated by histamine H1 receptor antagonism has yet to be demonstrated. ...
In addition to their primary mechanism of antagonising histamine at the H1 receptor, these agents may act on other mediators of the a …
[Cetirizine]
Groschner K and Pöch G. Dtsch Med Wochenschr 1998 - Review. PMID 9879282 German.
Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
Simons FE and Simons KJ. Clin Pharmacokinet 1991 - Review. PMID 1685361
Second-generation, relatively nonsedating histamine H1-receptor antagonists (H1-RA) are extensively used worldwide for the symptomatic treatment of allergic rhinoconjunctivitis and chronic urticaria. ...
Second-generation, relatively nonsedating histamine H1-receptor antagonists (H1-RA) are extensively used worldwide for the symptomati …
Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children.
Sarashina A, et al. Br J Clin Pharmacol 2005 - Clinical Trial. PMID 15606439 Free PMC article.
AIMS: Our objective was to develop a population pharmacokinetic (PPK) model for epinastine, a histamine H(1) receptor antagonist, in adults and children and to obtain pharmacokinetic information to support dosing recommendations in children. ...
AIMS: Our objective was to develop a population pharmacokinetic (PPK) model for epinastine, a histamine H(1) receptor antagonist, in …
341 results
Jump to page
Feedback